Sign in

CIK 0001725430

  • Non-accelerated filer
  • Smaller reporting company

INTELLIGENT BIO SOLUTIONS INC.

Sign in to watch
Ticker
INBS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
821512711
Phone
+1 646-790-5756
Business address
135 W 41ST ST,, FLOOR 5, NEW YORK, NY, 10036
Former names
GBS Inc., Glucose Biosensor Systems (Greater China) Holdings, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-18 Sakiris Spiro Kevin Chief Financial Officer Grant or award +9,150 12,631
2026-03-18 Sakiris Spiro Kevin Chief Financial Officer Grant or award +21,350 33,981
2024-09-25 Sakiris Spiro Kevin Chief Financial Officer Grant or award +34,500 34,815
2024-09-25 Sakiris Spiro Kevin Chief Financial Officer Grant or award +34,500 34,815
2024-03-20 Sakiris Spiro Kevin Chief Financial Officer Option exercise +9,394 19,180
2024-03-20 Sakiris Spiro Kevin Chief Financial Officer Option exercise · Common Stock Warrants (Series F) −9,394 0
2023-10-04 Sakiris Spiro Kevin Chief Financial Officer Purchase +112,727 117,427
2023-10-04 Sakiris Spiro Kevin Chief Financial Officer Purchase · Common Stock Warrants (Series E) +112,727 112,727
2023-10-04 Sakiris Spiro Kevin Chief Financial Officer Purchase · Common Stock Warrants (Series F) +112,727 112,727
2023-05-10 Sakiris Spiro Kevin Chief Financial Officer Conversion +2,399 $5.80 $14K 4,745
2023-05-10 Sakiris Spiro Kevin Chief Financial Officer Conversion · Series D Convertible Preferred Stock −15,993 0
2022-12-22 Sakiris Spiro Kevin Chief Financial Officer Purchase · Series D Convertible Preferred Stock +15,992 $0.87 $14K 15,993
2022-12-22 Sakiris Spiro Kevin Chief Financial Officer Purchase · Common Stock Purchase Warrant +47,979 $0.13 $6K 47,979
2022-10-10 Sakiris Spiro Kevin Chief Financial Officer Grant or award +75,000 125,228
2022-06-22 Sakiris Spiro Kevin Chief Financial Officer Purchase +5,000 $0.65 $3K 50,228
2022-06-17 Sakiris Spiro Kevin ChiefFinancial Officer Purchase +15,970 $0.61 $10K 45,228
2021-12-06 Sakiris Spiro Kevin ChiefFinancial Officer Purchase +10,000 $1.70 $17K 29,258
2021-05-19 Sakiris Spiro Kevin Chief Financial Officer Purchase +10,000 $3.07 $31K 16,258
2021-01-04 Sakiris Spiro Kevin Chief Financial Officer Option exercise +1,479 6,258
2021-01-04 Sakiris Spiro Kevin Chief Financial Officer Option exercise · Series B Warrants −1,479 0

Page 1 of 1 · 20 trades